Healthcare Innovations II, 8
Back to All Primary TrustsPortfolio Holdings by Security (As of Deposit Date)
| Ticker | Security Description | Deposit % |
|---|---|---|
| ACHV | ACHIEVE LIFE SCIENCES INC | 3.3 |
| ALLO | ALLOGENE THERAPEUTICS INC | 3.41 |
| ALVO | ALVOTECH SA | 3.33 |
| ANNX | ANNEXON INC | 3.24 |
| ARDX | ARDELYX INC | 3.37 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 3.32 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 3.38 |
| CADL | CANDEL THERAPEUTICS INC | 3.37 |
| CRSP | CRISPR THERAPEUTICS AG | 3.3 |
| HELP | HELUS PHARMA INC | 3.33 |
| HRMY | HARMONY BIOSCIENCES HOLDINGS | 3.35 |
| HROW | HARROW INC | 3.3 |
| IMCR | IMMUNOCORE HOLDINGS PLC-ADR | 3.35 |
| KURA | KURA ONCOLOGY INC | 3.17 |
| KYTX | KYVERNA THERAPEUTICS INC | 3.31 |
| MGTX | MEIRAGTX HOLDINGS PLC | 3.28 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 3.39 |
| NGNE | NEUROGENE INC | 3.44 |
| NPCE | NEUROPACE INC | 3.26 |
| OCGN | OCUGEN INC | 3.36 |
| OCS | OCULIS HOLDING AG | 3.36 |
| OPK | OPKO HEALTH INC | 3.33 |
| SLDB | SOLID BIOSCIENCES INC | 3.36 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 3.33 |
| SPRY | ARS PHARMACEUTICALS INC | 3.33 |
| TEVA | TEVA PHARMACEUTICAL IND LTD | 3.36 |
| TLX | TELIX PHARMACEUTICALS LTD | 3.36 |
| TSHA | TAYSHA GENE THERAPIES INC | 3.39 |
| URGN | UROGEN PHARMA LTD | 3.27 |
| VSTM | VERASTEM INC | 3.35 |
Health Care
| Ticker | Security Description | Deposit % |
|---|---|---|
| ACHV | ACHIEVE LIFE SCIENCES INC | 3.3 |
| ALLO | ALLOGENE THERAPEUTICS INC | 3.41 |
| ALVO | ALVOTECH SA | 3.33 |
| ANNX | ANNEXON INC | 3.24 |
| ARDX | ARDELYX INC | 3.37 |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 3.32 |
| BMRN | BIOMARIN PHARMACEUTICAL INC | 3.38 |
| CADL | CANDEL THERAPEUTICS INC | 3.37 |
| CRSP | CRISPR THERAPEUTICS AG | 3.3 |
| HELP | HELUS PHARMA INC | 3.33 |
| HRMY | HARMONY BIOSCIENCES HOLDINGS | 3.35 |
| HROW | HARROW INC | 3.3 |
| IMCR | IMMUNOCORE HOLDINGS PLC-ADR | 3.35 |
| KURA | KURA ONCOLOGY INC | 3.17 |
| KYTX | KYVERNA THERAPEUTICS INC | 3.31 |
| MGTX | MEIRAGTX HOLDINGS PLC | 3.28 |
| MLTX | MOONLAKE IMMUNOTHERAPEUTICS | 3.39 |
| NGNE | NEUROGENE INC | 3.44 |
| NPCE | NEUROPACE INC | 3.26 |
| OCGN | OCUGEN INC | 3.36 |
| OCS | OCULIS HOLDING AG | 3.36 |
| OPK | OPKO HEALTH INC | 3.33 |
| SLDB | SOLID BIOSCIENCES INC | 3.36 |
| SNDX | SYNDAX PHARMACEUTICALS INC | 3.33 |
| SPRY | ARS PHARMACEUTICALS INC | 3.33 |
| TEVA | TEVA PHARMACEUTICAL IND LTD | 3.36 |
| TLX | TELIX PHARMACEUTICALS LTD | 3.36 |
| TSHA | TAYSHA GENE THERAPIES INC | 3.39 |
| URGN | UROGEN PHARMA LTD | 3.27 |
| VSTM | VERASTEM INC | 3.35 |
Summary
Description
-
Trust Name Healthcare Innovations II, 8
-
Trust Symbol STHCHX
Deposit Data
-
Deposit Date 11/05/2026
-
Termination Date 11/02/2028
-
Minimum Investment 100
-
Distribution Frequency Monthly (if any)
-
Initial Public Offer Price $10.00
-
Historical 12-Month Dist.* 0.00
CUSIP
-
Cash Cusip 83208K465
-
Reinvest Cusip 83208K473
-
Fee Cash Cusip 83208K481
-
Fee Invest Cusip 83208K499
Documents
*The Historical 12-Month Distribution of Trust Holdings is as of 07/01/2025. If the Trust deposited after, or 90 days prior to, 07/01/2025, the distribution is as of deposit date. The Historical 12-Month Distribution is calculated by taking the weighted average of the regular income distributions paid by the securities included in the trust’s portfolio over the 12 months preceding the trust’s date of deposit reduced to account for the effects of trust fees and expenses. This historical distribution is for illustrative purposes only and is not indicative of amounts that will actually be distributed by the trust. The distributions paid by the trust may be higher or lower than the amount shown above due to factors including, but not limited to, changes in the price of trust units, changes (including reductions) in distributions paid by issuers, changes in actual trust expenses and sales of securities in the portfolio. There is no guarantee that the issuers of the securities included in the trust will pay any distributions in the future.